Processa enters ATM equity agreement to sell up to $2.4M in common stock

Processa Pharmaceuticals, Inc.

Sales agreement with A.G.P./Alliance Global Partners for at-the-market offering of up to $2.4 million.
Sales Agent receives up to 3% commission on gross proceeds from shares sold.
Net proceeds to fund R&D for oncology drug candidates and working capital.
Registration statement filed on May 21, 2024 but not yet effective.
Company is not obligated to sell any shares under the agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.